FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2900480779> ?p ?o ?g. }

• W2900480779 endingPage "133" @default.
• W2900480779 startingPage "117" @default.
• W2900480779 abstract "The aim of this study is to describe the disease burden and costs of herpes zoster (HZ) in the general adult Japanese population or patients with immunocompromised (IC) conditions or chronic disorders.A retrospective cohort study of individuals aged 18-74 years was conducted using January 2005 to December 2014 records from the Japan Medical Data Center claims database. Twenty-eight IC conditions and chronic disorders were defined by diagnosis codes and/or procedures/treatments. HZ and its related complications were identified. Incidence rates (IR), frequency of HZ-related complications, healthcare resource utilization (HRU), and direct medical costs were estimated. HRU and costs were estimated on a subcohort of HZ cases occurring April 2012-January 2014.The overall IR of HZ in the total cohort of 2,778,476 adults was 4.92/1000 person-years (PY) [95% confidence interval (CI): 4.86-4.98] and increased with age. The IR in the IC cohort (51,818 subjects) was 8.87/1000 PY (95% CI: 8.29-9.48), ranging from 5.55/1000 PY (95% CI: 4.26-7.09) in psoriasis to 151.68/1000 PY (95% CI: 111.45-201.71) in hematopoietic stem cell transplant recipients; most IRs were in the range 6-10/1000 PY. The IRs in individuals with chronic disorders were also relatively high, in the range 5.40-12.90/1000 PY. The frequency of postherpetic neuralgia was 4.01% (95% CI: 3.72-4.33) in the total cohort and 11.73% (95% CI: 9.01-14.93) in the IC cohort. The mean [standard deviation (SD)] number of outpatient visits was 3.4 (4.9) and 5.0 (5.7), respectively, and the proportion of HZ patients hospitalized was 2.20% and 6.70%, respectively. The mean (SD) direct medical cost per HZ episode was ¥34,664 (¥54,433) and ¥55,201 (¥92,642) in the total and IC cohort, respectively.The elevated burden of HZ in Japanese individuals harboring IC conditions and chronic disorders documented in our study underlines the need for prevention of HZ in people with these conditions.GlaxoSmithKline Biologicals SA." @default.
• W2900480779 created "2018-11-29" @default.
• W2900480779 creator A5012135091 @default.
• W2900480779 creator A5012539554 @default.
• W2900480779 creator A5033956905 @default.
• W2900480779 creator A5034146799 @default.
• W2900480779 creator A5043636404 @default.
• W2900480779 creator A5067123101 @default.
• W2900480779 creator A5072064149 @default.
• W2900480779 creator A5073058528 @default.
• W2900480779 creator A5080374235 @default.
• W2900480779 creator A5084194739 @default.
• W2900480779 creator A5087942315 @default.
• W2900480779 date "2018-11-19" @default.
• W2900480779 modified "2023-10-10" @default.
• W2900480779 title "Burden of Herpes Zoster in the Japanese Population with Immunocompromised/Chronic Disease Conditions: Results from a Cohort Study Claims Database from 2005–2014" @default.
• W2900480779 cites W1825495625 @default.
• W2900480779 cites W1928377279 @default.
• W2900480779 cites W1965296466 @default.
• W2900480779 cites W1996563874 @default.
• W2900480779 cites W2009736529 @default.
• W2900480779 cites W2014048798 @default.
• W2900480779 cites W2040947756 @default.
• W2900480779 cites W2061326496 @default.
• W2900480779 cites W2077233193 @default.
• W2900480779 cites W2077414259 @default.
• W2900480779 cites W2086454732 @default.
• W2900480779 cites W2088781858 @default.
• W2900480779 cites W2091217595 @default.
• W2900480779 cites W2121656227 @default.
• W2900480779 cites W2152734304 @default.
• W2900480779 cites W2158693133 @default.
• W2900480779 cites W2164445871 @default.
• W2900480779 cites W2164587440 @default.
• W2900480779 cites W2165582664 @default.
• W2900480779 cites W2189463427 @default.
• W2900480779 cites W2260310536 @default.
• W2900480779 cites W2405401092 @default.
• W2900480779 cites W2560751330 @default.
• W2900480779 cites W2733165904 @default.
• W2900480779 cites W2734980347 @default.
• W2900480779 cites W2761182014 @default.
• W2900480779 cites W2761391179 @default.
• W2900480779 cites W2806780319 @default.
• W2900480779 doi "https://doi.org/10.1007/s13555-018-0268-8" @default.
• W2900480779 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6380970" @default.
• W2900480779 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30456446" @default.
• W2900480779 hasPublicationYear "2018" @default.
• W2900480779 type Work @default.
• W2900480779 sameAs 2900480779 @default.
• W2900480779 citedByCount "18" @default.
• W2900480779 countsByYear W29004807792019 @default.
• W2900480779 countsByYear W29004807792020 @default.
• W2900480779 countsByYear W29004807792021 @default.
• W2900480779 countsByYear W29004807792022 @default.
• W2900480779 countsByYear W29004807792023 @default.
• W2900480779 crossrefType "journal-article" @default.
• W2900480779 hasAuthorship W2900480779A5012135091 @default.
• W2900480779 hasAuthorship W2900480779A5012539554 @default.
• W2900480779 hasAuthorship W2900480779A5033956905 @default.
• W2900480779 hasAuthorship W2900480779A5034146799 @default.
• W2900480779 hasAuthorship W2900480779A5043636404 @default.
• W2900480779 hasAuthorship W2900480779A5067123101 @default.
• W2900480779 hasAuthorship W2900480779A5072064149 @default.
• W2900480779 hasAuthorship W2900480779A5073058528 @default.
• W2900480779 hasAuthorship W2900480779A5080374235 @default.
• W2900480779 hasAuthorship W2900480779A5084194739 @default.
• W2900480779 hasAuthorship W2900480779A5087942315 @default.
• W2900480779 hasBestOaLocation W29004807791 @default.
• W2900480779 hasConcept C120665830 @default.
• W2900480779 hasConcept C121332964 @default.
• W2900480779 hasConcept C126322002 @default.
• W2900480779 hasConcept C142724271 @default.
• W2900480779 hasConcept C167135981 @default.
• W2900480779 hasConcept C187212893 @default.
• W2900480779 hasConcept C195910791 @default.
• W2900480779 hasConcept C201903717 @default.
• W2900480779 hasConcept C204787440 @default.
• W2900480779 hasConcept C2778866549 @default.
• W2900480779 hasConcept C2908647359 @default.
• W2900480779 hasConcept C41008148 @default.
• W2900480779 hasConcept C44249647 @default.
• W2900480779 hasConcept C45827449 @default.
• W2900480779 hasConcept C61511704 @default.
• W2900480779 hasConcept C71924100 @default.
• W2900480779 hasConcept C72563966 @default.
• W2900480779 hasConcept C77088390 @default.
• W2900480779 hasConcept C99454951 @default.
• W2900480779 hasConceptScore W2900480779C120665830 @default.
• W2900480779 hasConceptScore W2900480779C121332964 @default.
• W2900480779 hasConceptScore W2900480779C126322002 @default.
• W2900480779 hasConceptScore W2900480779C142724271 @default.
• W2900480779 hasConceptScore W2900480779C167135981 @default.
• W2900480779 hasConceptScore W2900480779C187212893 @default.
• W2900480779 hasConceptScore W2900480779C195910791 @default.
• W2900480779 hasConceptScore W2900480779C201903717 @default.
• W2900480779 hasConceptScore W2900480779C204787440 @default.
• W2900480779 hasConceptScore W2900480779C2778866549 @default.

• next